Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP397416.RAk8qrfx4_GDkoMEWuWwqkQ6fTcdjnRoVEBK1bGEzNGj8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP397416.RAk8qrfx4_GDkoMEWuWwqkQ6fTcdjnRoVEBK1bGEzNGj8130_assertion type Assertion NP397416.RAk8qrfx4_GDkoMEWuWwqkQ6fTcdjnRoVEBK1bGEzNGj8130_head.
- NP397416.RAk8qrfx4_GDkoMEWuWwqkQ6fTcdjnRoVEBK1bGEzNGj8130_assertion wasGeneratedBy ECO_0000203 NP397416.RAk8qrfx4_GDkoMEWuWwqkQ6fTcdjnRoVEBK1bGEzNGj8130_provenance.
- NP397416.RAk8qrfx4_GDkoMEWuWwqkQ6fTcdjnRoVEBK1bGEzNGj8130_assertion wasDerivedFrom befree-2016 NP397416.RAk8qrfx4_GDkoMEWuWwqkQ6fTcdjnRoVEBK1bGEzNGj8130_provenance.
- NP397416.RAk8qrfx4_GDkoMEWuWwqkQ6fTcdjnRoVEBK1bGEzNGj8130_assertion SIO_000772 12794243 NP397416.RAk8qrfx4_GDkoMEWuWwqkQ6fTcdjnRoVEBK1bGEzNGj8130_provenance.
- NP397416.RAk8qrfx4_GDkoMEWuWwqkQ6fTcdjnRoVEBK1bGEzNGj8130_assertion evidence source_evidence_literature NP397416.RAk8qrfx4_GDkoMEWuWwqkQ6fTcdjnRoVEBK1bGEzNGj8130_provenance.
- NP397416.RAk8qrfx4_GDkoMEWuWwqkQ6fTcdjnRoVEBK1bGEzNGj8130_assertion description "[Twenty-two lesions from 17 patients with IPMT, including 12 benign (IPMT Adenoma) and 10 malignant (IPMT Carcinoma In Situ [CIS] (n = 4) and Invasive IPMT (n = 6) lesions, were immunostained for Survivin, p53, Bcl-2 and Ki-67.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP397416.RAk8qrfx4_GDkoMEWuWwqkQ6fTcdjnRoVEBK1bGEzNGj8130_provenance.